Research Partnership is delighted to announce developments across the syndicated portfolio, which consists of two offerings: Living With and Therapy Watch.
A new syndicated business unit has been created, which will be led by Helen Parfitt who has been promoted to Senior Director, Head of Syndicated. Helen will spearhead a dynamic team dedicated to elevating our portfolio, launching cutting-edge syndicated services, and working closely with other companies under the Inizio umbrella to deliver unparalleled insights for clients.
In addition, Sarah Brown has joined as Director, Head of Portfolio for the syndicated team. With her extensive experience in syndicated quantitative tracking and related fields, Sarah has been instrumental in driving syndicated business growth in her previous roles. She brings a diverse range of therapeutic expertise, including Respiratory, Rare blood disorders, Retinal diseases, Anaemia in Chronic Kidney Disease, Virology, and Liver Diseases.
In this newly created position, Sarah will work closely with Helen to ensure the strategic growth plan for the overall syndicated business is achieved, and she will be taking over the management of Therapy Watch, a market-tracking solution based on real-world evidence from prescribing physicians.
CEO of Research Partnership, Gareth Phillips, commented “I am delighted to congratulate Helen on her new appointment and welcome Sarah to the syndicated division. Helen has an enormous amount of experience and I am certain she will succeed in leading and progressing our syndicated portfolio. Sarah brings a wealth of knowledge and fresh perspectives to the team. I look forward to their collaboration and synergy with the other product leads to provide exceptional insights for our clients”.
Find out more about our Syndicated Services Portfolio.